Fri.Sep 08, 2023

article thumbnail

Norovirus Vaccine Candidate Shows Positive Results in Phase 2 Trial

Drug Topics

Vaxart’s VP1-based bivalent oral tablet vaccine was developed to target the norovirus GI.1 Norwalk and GII.4 Sydney strains, which are the predominant strains affecting humans.

Vaccines 469
article thumbnail

Increased Vitamin D Intake Can Decrease Symptoms of Depression, Anxiety

Pharmacy Times

Although findings indicate a relationship between vitamin D and mood disorders, further research is needed to clarify efficacy of specific vitamin D levels, as well as supplement dose and form.

162
162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Study Highlights Importance of Mpox Vaccination

Drug Topics

Patients who were vaccinated and reinfected showed symptoms of few lesions, little mucosal disease, and minimal analgesia requirements.

Vaccines 307
article thumbnail

Study: Financial Incentives Increases PrEP Initiation, Adherence for HIV

Pharmacy Times

Applying novel and effective behavioral economics for pre-exposure prophylaxis dissemination programs could help to tailor the programs to the populations and settings of high HIV burden areas.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Video: The Importance of Charitable Patient Assistance Foundations

Drug Topics

Charitable patient assistance foundations do crucial work to help individuals access necessary health care.

307
307
article thumbnail

Research Identifies Defined Subtypes of Follicular Lymphoma, Marginal Zone Lymphoma

Pharmacy Times

Correctly diagnosing specific follicular lymphomas and marginal zone lymphomas requires knowledge of the clinical context, including the site of involvement, age, and clinical presentation.

145
145

More Trending

article thumbnail

Self-Care Measures Can Help Prevent and Treat Headaches

Pharmacy Times

Pharmacists can make clinical recommendations tailored to patients’ individual needs.

144
144
article thumbnail

STAT+: Why Novartis is changing the name of its research labs

STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy. The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis BioMedical Research. But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit.

139
139
article thumbnail

Next-Generation Therapy Analyzes Intestinal Phages, Propelling Future of C. difficile Treatment

Pharmacy Times

Using metagenomic information, the technology isolates phages whose enzymes can specifically target the bacteria that causes C. difficile infection.

139
139
article thumbnail

STAT+: Lawsuit raises antitrust and kickback allegations around cancer patient referrals

STAT

A large independent group of oncologists in Philadelphia is suing the area’s dominant hospital system, Jefferson Health, alleging the system is violating federal antitrust and kickback laws by creating a “concerted campaign to eliminate” the group’s “presence in the oncology marketplace.” The lawsuit resurfaces longstanding concerns associated with hospitals buying up physician groups and then forcing those physicians to refer patients to the hospitals&#

Hospitals 136
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Insulin Sensitizers May Be Making a Comeback

Pharmacy Times

Researchers Have Identified New Uses for Them, Including in the Treatment of Polycystic Ovary Syndrome and Infertility.

139
139
article thumbnail

Intermountain, UPMC switching from Oracle's Cerner EHR to Epic enterprisewide

Fierce Healthcare

Intermountain Healthcare, a health system that operates 33 hospitals across seven western states, is transitioning from Oracle Health's Cerner electronic health record to rival Epic, citing higher | Intermountain Healthcare, a health system that operates 33 hospitals across seven western states, is transitioning from Oracle Health's Cerner EHR to its rival Epic, citing higher physician satisfaction scores as one key factor.

Cerner 132
article thumbnail

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

Pharmacy Times

Although it has some daunting adverse effects, Glenn Short, PhD, said ibogaine offers unique biological and therapeutic effects.

139
139
article thumbnail

An uncommon thyroid diagnosis led to an unexpected, all-too-visible side effect

STAT

Annie Larsson, 40, is no stranger to chronic conditions. She was diagnosed with type 1 diabetes at a young age and had it “completely managed” for years. Then, right before the Covid pandemic began, she was diagnosed with Graves’ disease, a condition that can make a person’s thyroid overactive. A thyroid removal surgery later, all she had to worry about was taking her thyroid hormone replacement medication every day — a to-do she was accustomed to because of he

131
131
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Study: IVIG Worth Considering for Severe, Critical COVID-19 Infection

Pharmacy Times

Multiple studies show that it might be more effective to administer intravenous immunoglobulins at an earlier stage of disease progression.

137
137
article thumbnail

In advocates’ ongoing push for superbug funding, ‘$6 billion is nothing’

PharmaVoice

The PASTEUR Act is likely heading for another legislative blow, but advocates say they see a future for the mechanism to fund the battle against antimicrobial resistance.

130
130
article thumbnail

Point-of-Care Test Reagents Could Aid Risk Assessment for In-Home Care of Older Adults

Pharmacy Times

In addition to improving risk evaluation in older adults at home, point-of-care testing may help clinicians manage patients with dementia who cannot communicate and those living in depopulated areas.

article thumbnail

Opinion: How the drug price negotiation program could affect Medicare Part D beneficiaries

STAT

After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much has been discussed about the drugs that were selected and the magnitude of price decreases that can be achieved. Less attention has been given to what this all means for Medicare beneficiaries. The negotiation, informed by confidential data from manufacturers and analysis by the Centers for Medicare and Medicaid Services, will result in a maximum fair price for each drug, which will be announced Sep

129
129
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Breaking Barriers and Inspiring Change: Female Pharmacy Owner Paves the Way for Success in Independent Practice

Pharmacy Times

With pharmacies around the country shifting to provide more comprehensive care and becoming true health care destinations, Chichi Ilonzo Momah, PharmD, RPh said she is excited for the future of the field.

132
132
article thumbnail

House committees introduce new healthcare price transparency legislation

Fierce Healthcare

A trio of House committees unveiled new legislation (PDF) Friday to lower costs and increase transpar | Several house committees dropped new legislation Friday meant to improve price transparency for patients and employers. Here's what they're proposing.

124
124
article thumbnail

Phase 2 Study Shows Promising Results to Lower SBP, Treat Hypertension with Zilebesiran

Pharmacy Times

The Phase 2 KARDIA-1 Study met its primary endpoint of lower systolic blood pressure with the use of zilebesiran.

132
132
article thumbnail

Combining new and existing immunity: A 3D approach to killing cancer

pharmaphorum

Combining new and existing immunity: A 3D approach to killing cancer Mike.

article thumbnail

Phase 3 Study of Macitentan 75mg to Treat CTEPH Will Stop Research

Pharmacy Times

A phase 3 study assessing macitentan 75mg treatment for CTEPH was stopped, although another study using macitentan will continue.

123
123
article thumbnail

STAT+: House transparency, PBM reform bill gains bipartisan support

STAT

WASHINGTON — A Democrat has signed on to a legislative package that would require health care transparency by law and enact modest payment reforms to pharmacy middlemen and hospitals, increasing its chances of passing the House of Representatives. Republicans conceded to a few tweaks to the legislation to ensure that transparency regulations for hospitals were at least equal to current regulations, which gained the endorsement of House Energy and Commerce Committee ranking member Frank Pa

Packaging 120
article thumbnail

Seagen partners Nurix on 'degrader-antibody conjugates'

pharmaphorum

Seagen partners Nurix on 'degrader-antibody conjugates' Phil.

111
111
article thumbnail

STAT+: Pharmalittle: Novartis R&D hub’s name change reflects strategy shift; Lilly’s Mounjaro backed by U.K. watchdog

STAT

Good morning, Pharmalittle family! Adam Feuerstein here, filling in for Ed. My morning coffee was brewed with Peru Cajamarca beans, sourced by Equator and lightly roasted to reveal “notes of almond, tamarind and white grape.” Honestly, I’m not getting any of those flavors, but it’s still a damn good cup of joe. Very smooth.

109
109
article thumbnail

CV Sciences launches Reserve Sleep Gummies

Drug Store News

The Reserve Sleep Gummies contain melatonin and cannabinoids.

106
106
article thumbnail

Eloxx moves ahead with plans with gene therapy for rare kidney disorder

Pharmaceutical Technology

Eloxx has submitted an IND for a pivotal trial to study its Alport syndrome therapy ELX-02 following a positive Phase II data readout.

105
105
article thumbnail

CVS Health expands leadership responsibilities

Drug Store News

Several CVS Health executives now have expanded responsibilities, while the company also welcomes Brian Kane as president of Aetna.

106
106
article thumbnail

NICE recommends new type 2 diabetes treatment

European Pharmaceutical Review

Eli Lilly ’s Mounjaro (tirzepatide), has been recommended to treat poorly controlled type 2 diabetes in adults alongside diet and exercise. National Institute for Health and Care Excellence (NICE) final draft guidance recommends tirzepatide as a new treatment option for this indication. Compared with semaglutide , insulin therapy or a placebo, tirzepatide demonstrated that 81 percent to 97 percent of people achieved better glucose control in clinical trials.

FDA 105
article thumbnail

Giant Eagle partners with Instacart for same-day delivery

Drug Store News

Central Ohio and Indianapolis Instacart customers will now be able to order items for same-day delivery from Giant Eagle and Market District.

105
105
article thumbnail

Lift for Roche as Alnylam drug lowers blood pressure

pharmaphorum

Lift for Roche as Alnylam drug lowers blood pressure Phil.

105
105
article thumbnail

Organic India expands Tulsi Tea line

Drug Store News

Tulsi Sweet Rose, Assam Black Tea is a caffeinated blend with bioactive botanicals.

105
105